# Pantoprazole

## Pantoloc I.V. inj 40 mg

| TAH Drug Code      | [IPAN4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPAN4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Maintenance therapy of Erosive esophagitis. Gastroesophageal reflux disease. Gastric hypersecretion, Pathological. Zollinger-Ellison syndrome.                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Peptic or duodenal ulcer, Gastric ulcer & GERD: 40 mg IV infusion once daily Zollinger-Ellison syndrome Initial, 80 mg IV infusion QD- Q12H                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Known hypersensitivity including anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria to substituted benzimidazoles or any component of the product. Concomitant use with rilpivirine-containing products.                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Common Gastrointestinal: Abdominal pain (3% ), Diarrhea (4% ), Flatulence (4% ) Neurologic: Headache (5% ) Serious Dermatologic: Cutaneous lupus erythematosus Gastrointestinal: Atrophic gastritis, Clostridium difficile diarrhea, Fundic gland polyposis of stomach Hematologic: Thrombocytopenia (less than 1% ) Immunologic: Stevens-Johnson syndrome, Toxic epidermal necrolysis Musculoskeletal: Disorder of muscle, Fracture of bone, Osteoporosis-related, Hip fracture, Rhabdomyolysis Renal: Tubulointerstitial nephritis, acute |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/pantoprazole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

